PAUL TROMBLEY: Open Payments
NPI 1164593604 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$866 in 43 payments from 7 companies in 2025. Trend: 2023 $1,427 · 2024 $1,264 · 2025 $866
Food & beverage: $866
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $441 |
| Supernus Pharmaceuticals, Inc. | 9 | $226 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Lundbeck LLC | 2 | $46 |
| Corium, LLC | 2 | $44 |
| Tris Pharma Inc | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
Products named: VRAYLAR, Qelbree, REXULTI, Azstarys, Dyanavel XR, FANAPT.
Industry payments across NC — which companies pay providers there.
